Ferring and Rebiotix Release Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo

Press/Media: Research

PeriodJun 7 2021

Media coverage

1

Media coverage

  • TitleFerring and Rebiotix Release Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo
    Media name/outletProfessional Services Close-Up
    Country/TerritoryUnited States
    Date6/7/21
    PersonsChristine L.Y. Lee